The cost of a clinical trial with drugs depends on several factors, such as number of participants, number of countries, number of hospitals, therapeutic area, drug type, and the specific clinical tests and procedures required per protocol, among other aspects.
In this podcast we will discuss the general cost sections typically included in a Clinical Research Organization (CRO) quotation, including the total price of each section.
Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266 pledesma@sofpromed.com
You may also be interested…
A CRO is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
The cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively. Download CRO quotation.
How much does a clinical trial cost? Check this guide if you are planning the budget of your next clinical study.
Why are clinical trials so costly? How can you reduce clinical trial expenses?
Small biotech companies running trials should consider the option of working with small CROs to save costs.
Low-cost high-quality rater training services for CNS clinical trials. Ideal option for small biotech companies.
Low-cost CROs provide great advantages for small biotech companies. Run cheaper clinical trials with high quality.
Please contact us at info@sofpromed.com if you need a cost-efficient CRO to run a cheaper clinical trial The biotech industry is on the cusp of a remarkable transformation, with small startups poised to revolutionize medical care through innovative therapies and...
Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266 pledesma@sofpromed.com